Y. Mendoza-Marí

发表

Burn injury insulin resistance and central nervous system complications: A review

P. Valdés-Sosa, J. Berlanga-Acosta, Y. Mendoza-Marí, 2020 .

Epidermal growth factor effect on lipopolysaccharide-induced inflammation in fibroblasts derived from diabetic foot ulcer

J. Berlanga-Acosta, Y. Mendoza-Marí, Nadia Rodríguez-Rodríguez, 2022, Scars, burns & healing.

Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood

Iris Valdés, M. Béquet-Romero, G. Lemos, 2022, Clinical Immunology Communications.

GHRP-6 , a novel candidate for prevention and treatment of fibrotic disorders

J. Berlanga-Acosta, D. Vázquez-Blomquist, José Suárez-Alba, 2017 .

Growth hormone‐releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study

L. Betancourt, V. Besada, L. González, 2018, International wound journal.

Intralesional Infiltrations of Arteriosclerotic Tissue Cells-Free Filtrate Reproduce Vascular Pathology in Healthy Recipient Rats

R. Playford, J. Berlanga-Acosta, O. Reyes-Acosta, 2022, International journal of molecular sciences.

Review: Insulin resistance and mitochondrial dysfunction following severe burn injury

R. Playford, J. Berlanga-Acosta, Y. Mendoza-Marí, 2020, Peptides.

[Evaluation of the survival of bone marrow mononucleate cells transplanted in a rat model of striatal lesion with quinolinic acid].

E. Alberti-Amador, L. Blanco-Lezcano, Y. Mendoza-Marí, 2005, Revista de neurologia.

High glucose burden inhibits EGFR/PI3K/AKT1/mTOR signaling pathway in cutaneous fibroblasts

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2014 .

Cell-Free Filtrates (CFF) as Vectors of a Transmissible Pathologic Tissue Memory Code: A Hypothetical and Narrative Review

J. Berlanga-Acosta, Y. Mendoza-Marí, Diana García del Barco Herrera, 2022, International journal of molecular sciences.

Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects

J. Berlanga-Acosta, F. Hernández-Bernal, Y. Mendoza-Marí, 2017, Clinical Medicine Insights: Cardiology.

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis

M. Mahtab, G. Guillén, Sheikh M. F. Akbar, 2021, Euroasian journal of hepato-gastroenterology.

Detrimental impact of acute and chronic glucose burden in wound-healing cells : fibroblasts , myofibroblasts and vascular precursor cells

P. López-Saura, J. Berlanga-Acosta, Marianela García-Siverio, 2012 .

Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats.

N. Pavón‐Fuentes, L. Delgado-Roche, F. Riva, 2013, Toxicology and applied pharmacology.

Epidermal Growth Factor (EGF) intralesional infiltrations: From the bench to the diabetic ulcers cells

G. Nieto, J. Berlanga-Acosta, Y. Mendoza-Marí, 2019, Integrative Molecular Medicine.

Histological and Transcriptional Expression differences between Diabetic Foot and Pressure Ulcers

J. Berlanga-Acosta, José Suárez-Alba, Y. Mendoza-Marí, 2013 .

Impacto perjudicial del exceso agudo y crónico de glucosa en células involucradas en la cicatrización: fibroblastos, miofibroblastos y células precursoras vasculares

P. López-Saura, Marianela García-Siverio, Y. Mendoza-Marí, 2012 .

Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity

M. L. Bringas-Vega, P. Valdés-Sosa, J. Berlanga-Acosta, 2020, Frontiers in Endocrinology.

Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome

J. Fernández-Montequín, J. Berlanga-Acosta, H. Pérez-Saad, 2017, BioMed research international.

Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2021, MEDICC review.

Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation.

J. Berlanga-Acosta, Y. Mendoza-Marí, Ariana García-Ojalvo, 2020, MEDICC review.

Cellular and molecular insights into the wound healing mechanism in diabetes

J. Berlanga-Acosta, Y. Mendoza-Marí, Calixto Valdez-Pérez, 2010 .

Intralesional Infiltrations of Cell-Free Filtrates Derived from Human Diabetic Tissues Delay the Healing Process and Recreate Diabetes Histopathological Changes in Healthy Rats

R. Playford, J. Berlanga-Acosta, Y. Mendoza-Marí, 2021, Frontiers in Clinical Diabetes and Healthcare.

Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report

D. G. Armstrong, J. Berlanga-Acosta, Y. Mendoza-Marí, 2013, International wound journal.

Torpid Diabetic Wound Healing: Evidence on the Role of Epigenetic Forces

J. Berlanga-Acosta, Ileydis Iglesias-Marichal, A. García, 2015 .

Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds

M. Béquet-Romero, Y. Mendoza-Marí, Ariana García-Ojalvo, 2019, International wound journal.

Modulation of Inflammatory Response by Electromagnetic Field Stimulation in Traumatic Brain Injury in Yucatan Swine

Vikrant Rai, D. Miulli, James Brazdzionis, 2024, Journal of surgery and research.